CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2021; 42(06): 595-598
DOI: 10.1055/s-0041-1736431
Brief Communication

Hairy Cell Leukemia: Morphological and Immunophenotypic Characteristics of Seven Cases and Cyclin D1 Expression

Shruti Neelamegam Ramesh
1   Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
1   Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Amit K. Adhya
1   Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Ashutosh Panigrahi
2   Department of Medical Oncology/Hematology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Prabodha K. Das
2   Department of Medical Oncology/Hematology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Susama Patra
1   Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
› Author Affiliations
Funding None.

Abstract

Aberrant immunophenotypic expression in hairy cell leukemia (HCL), both at medullary and extramedullary sites, is not uncommonly reported in literature. Cyclin D1 positivity in HCL may mimic mantle cell lymphoma (MCL) morphologically, especially in the presence of aberrant CD5 immunopositivity, requiring BRAFV600E mutation and/or CCND1 gene testing for confirmation. Here, we describe seven cases of HCL with clinicomorphological and immunophenotypic characteristics with an emphasis on cyclin D1 expression using immunohistochemistry (IHC) with a brief comprehensive literature review. We suggest that cyclin D1 positive HCL may be a distinct subtype which requires further immunophenotypic and molecular characterization for accurate diagnosis and planning of definitive therapy.

Authors' Contributions

S.N.: data collection and analysis, literature review, writing of the first manuscript draft. S.P.: conceptual design, diagnosis, data analysis, literature review, review, and editing of manuscript. A.K.A. and S.P.: interpretation of data, diagnosis, and review of manuscript for intellectual contents. A.P. and P.K.D.: management of cases and review of manuscript for intellectual content.


Supplementary Material



Publication History

Article published online:
30 December 2021

© 2021. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Tóth-Lipták J, Piukovics K, Borbényi Z, Demeter J, Bagdi E, Krenács L. A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies–a tissue microarray study. Pathol Oncol Res 2015; 21 (01) 203-211
  • 2 Bibi A, Java S, Chaudhary S. et al. BRAFV600E mutation in hairy cell leukemia: A single-center experience. Indian J Pathol Microbiol 2018; 61 (04) 532-536
  • 3 Pattnaik SA, Padhi S, Chhabra G. et al. Atypical presentation of hairy cell leukemia: a report and comprehensive review. Blood Res 2020; 55 (02) 123-127
  • 4 Jain D, Dorwal P, Gajendra S, Pande A, Mehra S, Sachdev R. CD5 positive hairy cell leukemia: a rare case report with brief review of literature. Cytometry B Clin Cytom 2016; 90 (05) 467-472
  • 5 Cortazar JM, DeAngelo DJ, Pinkus GS, Morgan EA. Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissues. Histopathology 2017; 71 (01) 112-124
  • 6 Rahman ZA, Muwalla F, Jiang L, Foran J. Hairy cell leukemia with CCND1/IGH fusion gene and BRAF V600E mutation. Leuk Res Rep 2020; 13: 100197
  • 7 Morgan EA, Katzman LE, Georgian-Smith D, Owings RA, Pinkus GS, Deangelo DJ. Hairy cell leukemia presenting as a palpable breast mass. J Hematop 2014; 7: 181-187
  • 8 Miranda RN, Briggs RC, Kinney MC, Veno PA, Hammer RD, Cousar JB. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Mod Pathol 2000; 13 (12) 1308-1314
  • 9 Sherman MJ, Hanson CA, Hoyer JD. An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia. Am J Clin Pathol 2011; 136 (03) 390-399
  • 10 Chen D, Ketterling RP, Hanson CA, Colgan JP, Zent CS, Viswanatha DS. A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited. Am J Surg Pathol 2011; 35 (07) 1080-1084
  • 11 Chai KL, Morris T, Bazargan A. A case report of hairy cell leukemia: an unusual presentation. Ann Clin Case Rep 2017; 2: 1412
  • 12 Ishida F, Kitano K, Ichikawa N. et al. Hairy cell leukemia with translocation (11;20)(q13;q11) and overexpression of cyclin D1. Leuk Res 1999; 23 (08) 763-765